AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:100 mg Fmoc-Asn(α-L-Fuc(Ac)3(1-6)-β-D-GlcNAc(Ac)2)-OH

Fmoc-Asn(α-L-Fuc(Ac)3(1-6)-β-D-GlcNAc(Ac)2)-OH

C97H151N23O35S / 2233

used to build proteoglycan-related glycopeptides

6-O-disulfated glucosamine (GlcNS6S)

32 / A synthetic heparan sulfate (HS) / heparin disaccharide bearing iduronic acid (IdoA) linked to 2-N-sulfated glucosamine (GlcNS)

AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:100 mg Fmoc-Asn(α-L-Fuc(Ac)3(1-6)-β-D-GlcNAc(Ac)2)-OHC13H23NO8 321. 32 A D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a short butyl spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl (PFP) esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form stable amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the